Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1439 JH-LPH-28Summary: JH-LPH-28, a sulfonylpiperazine analog, is a potent inhibitor of UDP-2,3-diacylglucosamine pyrophosphate hydrolase. -
BA1442 GWP-042Summary: GWP-042 is a potent inhibitor of Mycobacterium alanine dehydrogenase (Ald) Rv2780. -
BA1444 MeptyldinocapSummary: A new fungicide for powdery mildew (powdery mildew). -
BA1449 PA3552-IN-1Summary: PA3552-IN-1 (Compound 15) is an antibiotic adjuvant that restores the susceptibility of MDR Pseudomonas aeruginosa DK2 strain to PolymyxinB. -
BA1450 PK150Summary: PK150 is a Sorafenib analog. -
BA1451 DprE1-IN-2Summary: DprE1-IN-2 (compound 18) was a potent inhibitor. -
BA1452 MAC-545496Summary: MAC-545496 is a nanomolar inhibitor of glycopeptide resistance-associated protein R. -
BA1453 TerizidoneSummary: Terizidone is an antimicrobial agent with bacteriostatic activity. -
BA1454 PanobacumabSummary: Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody. -
BA1455 MBX-4132Summary: MBX-4132 is an oxadiazole.

